← Back to catalogue
Published

metamyelocyte

vr.tr.metamyelocyte · thing-q3299749

Enable an agent to recognize a metamyelocyte, record evidence for its granulocytic maturation stage, and determine whether its identification and specimen context require further review.

Thing Registry Physical world and living systems PHY.OBJ

Bundle → Layer → Finding → Questions Filled

6 bundles · 11 layers · 16 findings · 26 questions

Stage and lineage Establish what the metamyelocyte label identifies and how lineage qualifies it.

Stage boundaries

Locate the candidate between neighboring granulocytic stages.

Metamyelocyte stage assignment

Require an explicit staging convention and record competing assignments near the myelocyte and band boundaries.

  1. Which morphological criteria establish the metamyelocyte stage in the applicable species and lineage? definition
  2. Which observed feature excludes a myelocyte or band-cell assignment, and where does ambiguity remain? boundary

Lineage attribution

Distinguish maturation-stage evidence from evidence for granulocyte lineage.

Granulocyte lineage evidence

Record the lineage supported by granulation and any additional evidence, retaining unresolved cases.

  1. Which granule features support neutrophilic, eosinophilic or basophilic attribution under this stain? definition
  2. Can the stage be identified while lineage remains unresolved, and how should that result be represented? boundary
Morphological recognition Capture the visible features needed to recognize and challenge a metamyelocyte identification.

Nuclear morphology

Assess indentation, segmentation and chromatin as separate observations.

Indentation and chromatin

The ASH neutrophilic example supports recording shallow nuclear indentation and condensed chromatin together. [ASH metamyelocyte](https://imagebank.hematology.org/image/60398/metamyelocyte)

  1. How are indentation depth and its reference nuclear dimension defined and measured? measurement
  2. Do segmentation and chromatin support the assigned stage, or suggest a competing cell identity? boundary

Cytoplasmic morphology

Record lineage-compatible granulation, cytoplasmic appearance and cell dimensions.

Granulation and cell proportions

Preserve granule appearance and calibrated dimensions as evidence rather than relying on the nuclear silhouette alone.

  1. What granule color, abundance and distribution are visible under the recorded staining conditions? measurement
  2. Which cytoplasmic and nuclear features distinguish this candidate from a monocyte or earlier granulocytic precursor? boundary
Maturation and cell state Relate the stage assignment to developmental progression while separating expected biology from observed state.

Developmental relations

Connect the stage to its precursor and subsequent maturation stages.

Maturation sequence evidence

Represent predecessor and successor relationships with species and lineage qualifications.

  1. Which precursor and successor stages are recognized for this lineage under the chosen nomenclature? definition
  2. Is the developmental relationship inferred from morphology or supported by lineage tracing or serial observation? provenance

Proliferation and integrity

Keep cell-cycle expectations and integrity observations separate from stage classification.

Stage-state discordance

Make apparent division, degeneration or assay evidence that conflicts with the stage assignment reviewable.

  1. What evidence establishes the proliferation status expected at this stage, and was proliferation measured in this cell? provenance
  2. Should apparent mitosis or severe degeneration trigger reclassification, an uncertainty flag or specialist review? action
Specimen occurrence and counting Connect individual metamyelocytes to their anatomical compartment and specimen-level abundance.

Compartment context

Interpret occurrence in relation to specimen origin and organism context.

Marrow versus circulation

ASH describes peripheral-blood metamyelocytes in several reactive and neoplastic settings; occurrence alone therefore does not identify a cause. [ASH metamyelocyte](https://imagebank.hematology.org/image/60398/metamyelocyte)

  1. Was the cell observed in marrow, peripheral blood, another tissue or culture, and how was that origin established? provenance
  2. Which species-, age- and specimen-specific expectations determine whether its occurrence needs review? boundary

Differential enumeration

Represent stage-specific counts without conflating them with broader immature-granulocyte categories.

Count denominator and category

Link counted metamyelocytes to the counting method, total examined population and laboratory category definition.

  1. How many metamyelocytes were identified among how many cells, and what population forms the denominator? measurement
  2. Does the reported immature-granulocyte result resolve metamyelocytes separately or combine several maturation stages? boundary
Identification quality and review Preserve the evidence and limitations governing acceptance of a metamyelocyte label.

Observation quality

Assess whether preparation and imaging permit reliable evaluation of stage-defining features.

Assessability of stage features

Record whether nuclear contour, chromatin and granules remain interpretable despite overlap, distortion or staining limitations.

  1. Which preparation, stain, image calibration and cell image support this identification? provenance
  2. Are artifacts severe enough to prevent assessment of indentation, segmentation or granulation? measurement

Classification resolution

Resolve uncertain or discordant stage assignments through documented review.

Reviewable stage decision

Retain the initial label, alternative classifications and the basis of any reviewer correction.

  1. Which alternative cell identities remain plausible, and what evidence would resolve them? boundary
  2. Should the agent accept the label, request another image or route the cell for qualified morphology review? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these check these first hold for the sense of metamyelocyte this model covers, and on what evidence? provenance

Kinds and varieties

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these kinds and varieties hold for the sense of metamyelocyte this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these real-world use hold for the sense of metamyelocyte this model covers, and on what evidence? provenance

Typical measurements

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these typical measurements hold for the sense of metamyelocyte this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these failure modes and hazards hold for the sense of metamyelocyte this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of metamyelocyte this model covers, and on what evidence? provenance

Classifiers Filled

Family
Thing Registry
Category
Physical world and living systems
Entry kind
thing
Plane
PHY
Domain
PHY.OBJ
Other names and narrower kinds
eosinophilic metamyelocyte, neutrophilic metamyelocyte, basophilic metamyelocyte

What it is Filled

A metamyelocyte is a postmitotic, immature granulocyte that develops from a myelocyte and has lineage-specific cytoplasmic granules and an indented, typically kidney-shaped nucleus.

In scope

  • Recognition of the metamyelocyte stage within granulocytic maturation
  • Neutrophilic, eosinophilic, basophilic or unresolved lineage attribution
  • Nuclear indentation, chromatin and cytoplasmic granulation
  • Cell-level observations linked to marrow, blood or experimental specimens
  • Stage-specific counting, classification confidence and review decisions

Out of scope

  • The complete granulopoiesis process and its systemic regulation
  • Myelocytes, band granulocytes and segmented granulocytes as independently modeled stages
  • Monocyte development and identification beyond differential exclusion
  • Whole-patient diagnosis, prognosis and treatment selection
  • Laboratory instruments, staining reagents and specimen collection procedures
  • Complete blood-count interpretation and population reference-interval maintenance

Why it exists Filled

Enable an agent to recognize a metamyelocyte, record evidence for its granulocytic maturation stage, and determine whether its identification and specimen context require further review.

Distinguishing features Filled

  • For a human neutrophilic candidate, assess an indented, unsegmented nucleus with condensed chromatin; the ASH example describes indentation less than half the nuclear diameter. Record the convention used at the band-cell boundary. [ASH metamyelocyte](https://imagebank.hematology.org/image/60398/metamyelocyte)
  • Against a myelocyte candidate, require evidence that the nuclear contour has entered the indented metamyelocyte stage under the applicable morphology convention.
  • Against a segmented granulocyte, check for absence of distinct nuclear lobes connected by thin filaments.
  • Against a monocyte or earlier granulocytic precursor, evaluate chromatin and lineage-compatible granulation together with nuclear contour; a kidney-shaped outline alone is insufficient.
  • Treat metamyelocyte as a maturation-stage identity rather than a synonym for neutrophil lineage: the broader granulocyte precursor category includes neutrophilic, eosinophilic and basophilic development. [NCBI MeSH: Granulocyte Precursor Cells](https://www.ncbi.nlm.nih.gov/mesh/D042381)

What robots and AI may and may not do Filled

Must not

  • Diagnose a disease such as leukaemia or infection from a metamyelocyte count.
  • Tell a patient that a result is normal or abnormal in place of their clinician.
  • Share a patient's blood results without consent.

Only with a human decision

  • Any clinical decision that follows from a blood film result.

May

  • Explain what a metamyelocyte is and where it appears in blood cell development.
  • Flag reported metamyelocyte counts on a blood test for clinician review.

Moral aspects Filled

  • Abnormal blood results can frighten patients; they must hear them from a clinician.
  • Blood test data are private health information.

Who is affected

  • Patients
  • Clinicians

Owners Filled

Steward

Nobody owns the cell type; the laboratory and treating clinician answer for each result.

Links to other meta-models Filled

parent

  • Q66590180 - registry parent class
  • Q7868 - registry parent class

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.metamyelocyte
  • Wikidata: Q3299749 (https://www.wikidata.org/wiki/Q3299749)

Direct properties required Filled

  • Granulocytic lineage: neutrophilic | eosinophilic | basophilic | unresolved
  • Species and developmental context: Link to organism species and age or developmental category
  • Nuclear indentation: Indentation depth divided by the explicitly defined nuclear reference dimension; dimensionless
  • Nuclear architecture: Contour description; segmentation absent | present | unresolved; chromatin condensed | intermediate | fine | unassessable
  • Cytoplasmic granulation: Granule color, coarseness, abundance and distribution under a named stain
  • Observed cell diameter: µm, with calibration and measurement method
  • Specimen compartment: Link to bone marrow | peripheral blood | other tissue | experimental culture specimen
  • Identification status: candidate | reviewer-confirmed | disputed | unclassifiable
  • Specimen-level abundance: Observed cell count; percentage with named denominator; cells/µL only when validly derived

Recognition required Filled

  • The nucleus is indented or kidney-shaped and lacks the distinct lobes of a segmented granulocyte.
  • Nuclear chromatin is condensed and nucleoli are generally not visible.
  • The cytoplasm contains lineage-specific granules that help distinguish granulocytic maturation from other cell lineages.
  • The nuclear indentation is typically shallower than that of a band granulocyte.

Capabilities and actions required Filled

  • Annotate a cell image with the nuclear and cytoplasmic evidence supporting metamyelocyte identification.
  • Compare a candidate with myelocyte, band granulocyte, segmented granulocyte and monocyte alternatives.
  • Assign a granulocytic lineage or retain an unresolved attribution.
  • Include a reviewed identification in a specimen differential with an explicit denominator.
  • Flag ambiguous staging, discordant morphology or specimen occurrence for qualified review.
  • Link repeated observations to a maturation experiment without inferring cell history from one fixed image.

Hazards and failure modes required Filled

  • Confusion with myelocytes or band granulocytes can distort differential counts and maturation assessments.
  • Treating the presence of metamyelocytes as diagnostic by itself can lead to unsupported clinical conclusions.
  • Poor specimen preservation or staining can obscure morphology and produce incorrect classification.
  • Blood and bone marrow specimens can expose handlers to biological hazards.

Standards and interfaces required Filled

  • ISO 15189, issued by the International Organization for Standardization, specifies quality and competence requirements for medical laboratories performing examinations such as blood cell morphology assessment.

Context of use required Filled

  • Metamyelocytes are encountered during examination of bone marrow as a normal stage of granulocyte maturation.
  • Their identification in peripheral blood contributes to assessment of immature granulocyte release and requires interpretation alongside the specimen and clinical context.

Sources Filled

  1. Wikidata item Q3299749: metamyelocyte - identity and sense of the item
  2. Wikipedia: Metamyelocyte - general description of the item

Open questions

  • Which authoritative staging conventions should govern indentation measurements and borderline myelocyte-metamyelocyte-band assignments?
  • How should recognition criteria vary across neutrophilic, eosinophilic and basophilic metamyelocytes and across species?
  • Which validated size distributions and specimen-occurrence expectations apply to the intended species, age groups and preparation methods?
  • Which assays independently support maturation and proliferation-state attribution, and how should disagreement with morphology be represented?
  • Which laboratory review rules and automated differential definitions permit a metamyelocyte-specific result rather than a combined immature-granulocyte category?

Machine files

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q3299749/spec.json